Home
Experience
Client Stories
industry
Healthcare & Life Sciences

Pharma carve-out needs a standalone finance function

Context

A $400M US and UK pharmaceutical device business, carved out of a $30B Global 100 company that would not share transferring employees, needed transition leadership and a new finance function.

Value Created

Achieved Day 1 readiness
with independent functions live and full business continuity
Stood up a finance team
by designing the org, hiring, and setting delegation of authority
Ensured ERP continuity
with future-state F&A and IT enterprise architecture planning

People

VALUE LEVERS

  1. Transition office leadership
  2. Finance team hiring

HOW WE DID IT

  • Led executives, functional leads, and advisor network
  • Designed the org, hired staff, and set delegation of authority

Process

VALUE LEVERS

  1. Carve-out planning & execution
  2. Finance function design
  3. 13-week cash flow forecasting

HOW WE DID IT

  • Built and tracked detailed Day 1 separation plans
  • Negotiated TSA items and filed license applications
  • Opened bank accounts, built cash forecast

Technology

VALUE LEVERS

  1. ERP implementation
  2. Payroll and T&E systems

HOW WE DID IT

  • Planned future-state F&A and IT architecture for ERP transition
  • Readied T&E and payroll systems for Day 1